Clinical Compliance & Algorithmic Ethics

Fundamental Operational Directive

Sauti Care strictly operates as an assistive Clinical Decision Support System (CDSS) classified under Software as a Medical Device (SaMD) risk guidelines. The system augments cognitive load; it does not autonomously diagnose or dictate interventional care. The licensed human clinician retains absolute sovereignty over the final triaging and therapeutic pathway.

Regulatory Alignment Matrix

Data Protection Act, 2019

Rigorous adherence to the Office of the Data Protection Commissioner (ODPC) mandates concerning the localized processing, encrypted storage, and authorized transmission of sensitive patient biometrics and clinical histories.

Institutional Review Boards (IRB)

All model training regimens and clinical validation deployments operate strictly under ethical clearance from designated partner hospital review boards and the Kenya Medical Research Institute (KEMRI) where applicable.

HL7 / FHIR Interoperability

Architectural compliance with Fast Healthcare Interoperability Resources (FHIR R4) to ensure that unstructured verbal inputs naturally synthesize into robust, standard-compliant semantic records compatible with dominant HMIS structures.

Algorithm Transparency

End-users are provided with explicability metrics (e.g., confidence interval percentages) accompanying all clinical insights, enabling rapid auditing of AI predictions against the ground-truth physical examination.

Proactive Bias Mitigation & Global South Representation

Machine learning topologies natively trained on Western cohorts historically exhibit unacceptable fault rates, hallucination variances, and phonetic misinterpretations when deployed in sub-Saharan contexts. Sauti Care is architected explicitly to solve this systemic failure. Our proprietary acoustic models (Wav2Vec2.0 derivations) and Computer Vision CNNs are rigorously fine-tuned and validated against localized datasets consisting of diverse linguistic accents (Swahili, English code-switching) and region-specific pathological markers. Continuous post-market auditing of the model's predictive validity ensures performance drift is detected and corrected proactively.